Publication & Citation Trends
Most Cited Works
Publications
74 total
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Cited by 202
OpenAlex
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis PDF
Cited by 62
OpenAlex
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy PDF
Cited by 101
OpenAlex
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Cited by 454
OpenAlex
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer PDF
Cited by 94
OpenAlex
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials PDF
Cited by 236
OpenAlex
The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection PDF
Cited by 196
OpenAlex
Research Topics
Hepatitis C virus research
(17)
HIV/AIDS drug development and treatment
(9)
HER2/EGFR in Cancer Research
(6)
CAR-T cell therapy research
(6)
Hepatitis B Virus Studies
(5)
Frequent Co-Authors
Affiliations
Jiangsu University
Tufts University
Brigham and Women's Hospital
University of Minnesota
Harvard University